Clinical Research Directory
Browse clinical research sites, groups, and studies.
Back to Studies
RECRUITING
NCT07091526
Whether Control of Serum Uric Acid (SUA) Improves Survival After Pancreatic Cancer
Sponsor: Hepatopancreatobiliary Surgery Institute of Gansu Province
View on ClinicalTrials.gov
Summary
This retrospective study aims to analyze the impact of postoperative changes in serum uric acid (SUA) levels on the prognosis of patients undergoing pancreatic cancer resection.
Official title: Whether Controlling Serum Uric Acid (SUA) Can Benefit Postoperative Survival in Patients With Pancreatic Cancer
Key Details
Gender
All
Age Range
18 Years - 85 Years
Study Type
OBSERVATIONAL
Enrollment
168
Start Date
2025-07-29
Completion Date
2026-12-29
Last Updated
2025-12-19
Healthy Volunteers
No
Conditions
Interventions
DIAGNOSTIC_TEST
serum uric acid test
Detect the serum uric acid in blood sample
Locations (1)
Hepatopancreatobiliary Surgery Institute of Gansu Province
Lanzhou, Gansu, China